Search

Press release

All Evonik production sites meet GMP standards for cosmetics

Essen, December 17, 2015

Cosmetic GMP certification for Evonik’s Americana site in Brazil means that all twelve Evonik sites that produce products for the Personal Care Business Line now meet ISO 22716 standards. Certification guarantees that Evonik is in compliance with all mandatory quality assurance requirements for manufacturing, monitoring, storing, and distributing raw materials for the cosmetics industry.

The company’s European sites, which had been certified as meeting GMP requirements for cosmetics back in 2012, were recertified for the first time at the end of fall 2015. Evonik’s North American and Asian production facilities for cosmetic ingredients were confirmed as GMP compliant in 2013 and 2014.

"We can now demonstrate that all of our sites throughout the world work according to uniform standards and at the same level of quality," says Dr. Tammo Boinowitz, head of Evonik’s Personal Care Business Line.

In addition, an integrated quality and environmental management system has also been established at all sites and certified as ISO 9001 and 14001 compliant. "That’s yet another way that we meet the high standards of our global customers," Boinowitz points out. If interested, please visit the Personal Care web page and read more about the business line’s quality policies.

Downloads

Contact

Dr. Jürgen Krauter

Communication Nutrition & Care

Lisa Dierks

Personal Care

  • About Nutrition & Care

    The Nutrition & Care segment is led by Evonik Nutrition & Care GmbH and contributes to fulfilling basic human needs. That includes applications for everyday consumer goods as well as animal nutrition and health care. This segment employed about 7,000 employees, and generated sales of around €4.2 billion in 2014.

  • About Evonik

    Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals, operating in the Nutrition & Care, Resource Efficiency and Performance Materials segments. The company benefits from its innovative prowess and integrated technology platforms. In 2014 more than 33,000 employees generated sales of around €12.9 billion.

  • Disclaimer

    In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.